Atopic irritable bowel syndrome: A novel subgroup of irritable bowel syndrome with allergic manifestations

Annals of Allergy, Asthma and Immunology

Volumn 100, Issue 1, 2008, Pages 49-53

  Tobin, Mary C ^a   Moparty, Bhavani ^a   Farhadi, Ashkan ^a   DeMeo, Mark T ^a   Bansal, Priya J ^a   Keshavarzian, Ali ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATOPY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; STRUCTURED INTERVIEW; SYMPTOM;

EID: 37849026737     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60404-8     Document Type: Article

References (35)

1. Horwitz BJ, Fisher RS. The irritable bowel syndrome. N Engl J Med. 2001;344:1846-1850.
2. McKendrick MW, Read NW. Irritable bowel syndrome: post salmonella infection. J Infect. 1994;29:1-3.
3. Mayer EA, Collins SM. Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology. 2002;122:2032-2048.
4. Kennedy TM, Jones RH, Hungin AP, O'Flanagan H, Kelly P. Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyperresponsiveness in the general population. Gut. 1998;43:770-774.
5. Yazar A, Atis S, Konca K, et al. Respiratory symptoms and pulmonary functional changes in patients with irritable bowel syndrome. Am J Gastroenterol. 2001;96:1511-1516.
6. The Allergy Report. Milwaukee, WI: American Academy of Allergy, Asthma, and Immunology; 1996-2005.
7. Stefanini GF, Saggioro A, Alvisi V, et al. Oral cromolyn sodium in comparison with elimination diet in the irritable bowel syndrome, diarrheic type: multicenter study of 428 patients. Scand J Gastroenterol. 1995;30:535-541.
8. Sampson HA. Food allergy, part 1: immunopathogenesis and clinical disorders. J Allergy Clin Immunol. 1999;103(pt 1):717-728.
9. Dunlop SP, Hebden J, Campbell E, et al. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol. 2006;101:1288-1294.
10. Petitpierre M, Gumowski P, Girard JP. Irritable bowel syndrome and hypersensitivity to food. Ann Allergy. 1985;54:538-540.
11. Magnusson J, Lin XP, Dahlman-Höglund A, et al. Seasonal intestinal inflammation in patients with birch pollen allergy. J Allergy Clin Immunol. 2003;112:45-50.
12. Weston AP, Biddle WL, Bhatia PS, Miner PB. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci. 1993;38: 1590-1595.
13. Chadwick VS, Chen W, Shu D, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology. 2002;122: 1778-1783.
14. Castells M, Austen KF. Mastocytosis: mediator-related signs and symptoms. Int Arch Allergy Immunol. 2002;127:147-152.
15. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology. 2002;123: 2108-2131.
16. Breiteneder H, Ebner C. Molecular and biochemical classification of plant-derived food allergens. J Allergy Clin Immunol. 2000;106(pt 1): 27-36.
17. Sicherer SH, Sampson HA. 9: food allergy. J Allergy Clin Immunol. 2006;117(suppl Mini-Primer):S470-S475.
18. Sicherer SH. Clinical implications of cross-reactive food allergens. J Allergy Clin Immunol. 2001;108:881-890.
19. Ma S, Sicherer SH, Nowak-Wegrzyn A. A survey on the management of pollen-food allergy syndrome in allergy practices. J Allergy Clin Immunol. 2003;112:784-788.
20. Monsbakken KW, Vandvik PO, Farup PG. Perceived food intolerance in subjects with irritable bowel syndrome: etiology, prevalence and consequences. Eur J Clin Nutr. 2006;60:667-672.
21. Atkinson W, Sheldon TA, Shaath N, Whorwell PJ. Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut. 2004;53:1459-1464.
22. Zar S, Mincher L, Benson MJ, Kumar D. Food-specific IgG4 antibody-guided exclusion diet improves symptoms and rectal compliance in irritable bowel syndrome. Scand J Gastroenterol. 2005;40:800-807.
23. Hahn EL, Bacharier LB. The atopic march: the pattern of allergic disease development in childhood. Immunol Allergy Clin North Am. 2005;25: 231-246.
24. Bansal PJ, Moparty B, Farhardi A, DeMeo M, Keshavarzian A, Tobin MC. Atopic dermatitis as an allergic marker for irritable bowel syndrome. J Allergy Clin Immunol. 2003;111:S157.
25. Wood JD. Enteric neuroimmunophysiology and pathophysiology. Gastroenterology. 2004;127:635-657.
26. Wright R. Stress and atopic disorders. J Allergy Clin Immunol. 2005; 116:1301-1306.
27. Cole JA, Rothman KJ, Cabral HJ, Zhang Y, Farraye FA. Migraine, fibromyalgia, and depression among people with IBS: a prevalence study. BMC Gastroenterol. 2006;6:26.
28. Martinez V, Tache Y. CRF1 receptors as a therapeutic target for irritable bowel syndrome. Curr Pharm Des. 2006;12:4071-4088.
29. Barbara G, Stanghellini V, De Giorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126:693-702.
30. Santos J, Saperas E, Nogueiras C, et al. Release of mast cell mediators into the jejunum by cold pain stress in humans. Gastroenterology. 1998;114:640-648.
31. Crowe SE, Perdue MH. Functional abnormalities in the intestine associated with mucosal mast cell activation. Reg Immunol. 1992;4:113-117.
32. Jakate S, Demeo M, John R, Tobin M, Keshavarzian A. Mastocytic enterocolitis: increased mucosal mast cells in chronic intractable diarrhea. Arch Pathol Lab Med. 2006;130:362-367.
33. Lunardi C, Bambara LM, Biasi D, et al. Double-blind cross-over trial of oral sodium cromoglycate in patients with irritable bowel syndrome due to food intolerance. Clin Exp Allergy. 1991;21:569-572.
34. Stefanini GF, Prati E, Albini MC, et al. Oral disodium cromoglycate treatment on irritable bowel syndrome: an open study on 101 subjects with diarrheic type. Am J Gastroenterol. 1992;87:55-57.
35. Zar S, Kumar D, Benson MJ. Food hypersensitivity and irritable bowel syndrome. Aliment Pharmacol Ther. 2001;15:439-449.